Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,858.00
Bid: 6,847.00
Ask: 6,850.00
Change: 1.00 (0.01%)
Spread: 3.00 (0.04%)
Open: 6,800.00
High: 6,921.00
Low: 6,779.00
Yest. Close: 6,857.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Astra's Anifrolumab Shows Advantage Across Various Efficacy Endpoints

Astra's Anifrolumab Shows Advantage Across Various Efficacy Endpoints

12 Nov 19 08:56

AstraZeneca's anifrolumab succeeds in lupus study

(Sharecast News) - Biopharmaceutical giant AstraZeneca's anifrolumab demonstrated superiority across multiple efficacy endpoints versus placebos in the drug's Phase III TULIP 2 trial.

12 Nov 19 08:05

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

11 Nov 19 10:22

UPDATE 1-Rising HK tensions drag Asia-exposed UK stocks

* FTSE 100 down 0.6%, FTSE 250 down 0.2%* Baker Greggs jumps after forecast upgrade* Stocks vulnerable to Asia sink on Hong Kong tensions (Adds company news items, analyst comment, updates share moves)By Muvija M and Shashwat AwasthiNov 11 (Reuters)...

11 Nov 19 09:26

LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain

LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain

11 Nov 19 08:43

TOP NEWS: AstraZeneca Reports Positive Test Results For Anaemia Drug

TOP NEWS: AstraZeneca Reports Positive Test Results For Anaemia Drug

11 Nov 19 08:07

AstraZeneca upbeat on latest roxadustat trial data

(Sharecast News) - AstraZeneca, along with its partner FibroGen, presented pooled efficacy and cardiovascular safety analyses from the pivotal phase 3 programme assessing 'roxadustat' on Monday, for the treatment of patients with anaemia from chronic kidney disease (CKD).

11 Nov 19 07:55

UPDATE 1-Safety data on AstraZeneca anaemia drug points to potential use in dialysis

(Adds quotes, further details about drug, potential sales)FRANKFURT, Nov 8 (Reuters) - AstraZeneca said that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with ...

8 Nov 19 19:52

Safety data on AstraZeneca anaemia drug points to potential use in dialysis

FRANKFURT, Nov 8 (Reuters) - AstraZeneca said on Friday that safety data on roxadustat underpinned the British drugmaker's hopes for the anaemia drug to become a standard treatment for patients with kidney disease.It said pooled data from several ...

8 Nov 19 19:47

AstraZeneca Drug Roxadustat Increases Haemoglobin Levels In Two Trials

AstraZeneca Drug Roxadustat Increases Haemoglobin Levels In Two Trials

8 Nov 19 08:14

AstraZeneca reports positive trials for kidney drug

(Sharecast News) - AstraZeneca on Friday reported clinical trials of its roxadustat drug for patients with anaemia from chronic kidney disease had significantly increased red haemoglobin levels.

8 Nov 19 07:50

Thursday broker round-up

(Sharecast News) - Associated British Foods: Goldman Sachs upgrades to buy with a target price of 2,750p.

7 Nov 19 13:28

UPDATE: AstraZeneca To Present Encouraging Data From Calquence Trial

UPDATE: AstraZeneca To Present Encouraging Data From Calquence Trial

6 Nov 19 14:55

AstraZeneca Steps Up China Presence With USD1 Billion Fund, R&D Centre

AstraZeneca Steps Up China Presence With USD1 Billion Fund, R&D Centre

6 Nov 19 09:30

LONDON MARKET CLOSE: Mixed End Ahead Of US Fed Interest Rate Decision

LONDON MARKET CLOSE: Mixed End Ahead Of US Fed Interest Rate Decision

30 Oct 19 17:07

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.